Pharma and Biotech
Holding(s) in Company | 28-May-2025 | 07:30 | RNS |
Completion of the acquisition of Awakn | 28-May-2025 | 07:00 | RNS |
Publication of a Prospectus | 21-May-2025 | 15:24 | RNS |
Result of placing | 16-May-2025 | 07:31 | RNS |
Proposed equity fundraising via ABB | 15-May-2025 | 16:53 | RNS |
Result of General Meeting | 28-Apr-2025 | 11:30 | RNS |
Proposed acquisition of Awakn approved | 23-Apr-2025 | 07:00 | RNS |
Final Results for the year ended 31 December 2024 | 16-Apr-2025 | 07:00 | RNS |
Posting of Circular and Notice of General Meeting | 10-Apr-2025 | 14:00 | RNS |
Holding(s) in Company | 07-Apr-2025 | 07:00 | RNS |
Engagement of PharmaVentures | 04-Apr-2025 | 07:00 | RNS |
Positive progress on European Patent Application | 26-Mar-2025 | 07:00 | RNS |
Update on AWKN-SDN-14 programme | 18-Mar-2025 | 07:00 | RNS |
Holding(s) in Company | 11-Mar-2025 | 09:00 | RNS |
Appointment of Non-Executive Director | 11-Mar-2025 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 0.13p |
Change Today | 0.004p |
% Change | 3.05 % |
52 Week High | 1.01 |
52 Week Low | 0.12 |
Volume | 138,774,254 |
Shares Issued | 2,295.93m |
Market Cap | £3.08m |
Beta | 0.01 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:22 | 25,000 @ 0.14p |
15:22 | 2,000,000 @ 0.13p |
14:53 | 2,003,682 @ 0.13p |
14:47 | 2,346,154 @ 0.13p |
14:31 | 1,516,445 @ 0.13p |
CEO | Anthony Tennyson |
Chair | Dennis Purcell |
Finance Director | Ryan Neats |
You are here: research